182 related articles for article (PubMed ID: 34185227)
1. Incidence and patient characteristics of venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer.
Chokshi SK; Gaughan JP; Krill L
J Thromb Thrombolysis; 2022 Jan; 53(1):202-207. PubMed ID: 34185227
[TBL] [Abstract][Full Text] [Related]
2. Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy.
Basaran D; Boerner T; Suhner J; Sassine D; Liu Y; Grisham RN; Tew WP; Gardner GJ; Zivanovic O; Sonoda Y; Long Roche K; Chi DS; Abu-Rustum NR; Soff GA; Jewell EL
Gynecol Oncol; 2021 Oct; 163(1):36-40. PubMed ID: 34312001
[TBL] [Abstract][Full Text] [Related]
3. Assessing the need for venous thromboembolism prophylaxis at the time of neoadjuvant chemotherapy for ovarian cancer: A literature review.
Moufarrij S; Sassine D; Basaran D; Jewell EL
Gynecol Oncol; 2023 Mar; 170():167-171. PubMed ID: 36701837
[TBL] [Abstract][Full Text] [Related]
4. Venous Thromboembolism in Patients Receiving Neoadjuvant Chemotherapy for Advanced Ovarian Cancer and Impact on Survival.
Black KA; Ghosh S; Singh N; Chu P; Pin S
J Obstet Gynaecol Can; 2021 Dec; 43(12):1380-1387. PubMed ID: 34087490
[TBL] [Abstract][Full Text] [Related]
5. Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis?
Shafa A; Watkins AB; McGree ME; Weroha SJ; Wahner Hendrickson AE; Block MS; Langstraat CL; McBane RD; Bakkum-Gamez JN; Kumar A
Gynecol Oncol; 2023 Sep; 176():36-42. PubMed ID: 37442024
[TBL] [Abstract][Full Text] [Related]
6. Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer.
Salinaro JR; McQuillen K; Stemple M; Boccaccio R; Ehrisman J; Lorenzo AM; Havrilesky L; Secord AA; Galvan Turner V; Moore KN; Davidson B
Int J Gynecol Cancer; 2020 Apr; 30(4):491-497. PubMed ID: 32054646
[TBL] [Abstract][Full Text] [Related]
7. Incidence of venous thromboembolism after standard treatment in patients with epithelial ovarian cancer in Korea.
Shin W; Lee S; Lim MC; Jung J; Kim HJ; Cho H
Cancer Med; 2021 Mar; 10(6):2045-2053. PubMed ID: 33638309
[TBL] [Abstract][Full Text] [Related]
8. Incidence and Timing of Thromboembolic Events in Patients With Ovarian Cancer Undergoing Neoadjuvant Chemotherapy.
Greco PS; Bazzi AA; McLean K; Reynolds RK; Spencer RJ; Johnston CM; Liu JR; Uppal S
Obstet Gynecol; 2017 Jun; 129(6):979-985. PubMed ID: 28486358
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk of venous thromboembolism according to primary treatment in women with ovarian cancer: A retrospective cohort study.
Yuk JS; Lee B; Kim K; Kim MH; Seo YS; Hwang SO; Yoon SH; Kim YB
PLoS One; 2021; 16(4):e0250723. PubMed ID: 33909674
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism in women with ovarian cancer undergoing neoadjuvant chemotherapy prior to cytoreductive surgery: A retrospective study.
Oxley SG; Achampong YA; Sambandan N; Hughes DJ; Thomas M; Lockley M; Olaitan A
Acta Obstet Gynecol Scand; 2021 Nov; 100(11):2091-2096. PubMed ID: 34486103
[TBL] [Abstract][Full Text] [Related]
11. Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer.
Chavan DM; Huang Z; Song K; Parimi LRH; Yang XS; Zhang X; Liu P; Jiang J; Zhang Y; Kong B; Li L
Medicine (Baltimore); 2017 Oct; 96(42):e7935. PubMed ID: 29049188
[TBL] [Abstract][Full Text] [Related]
12. Incidence and Clinical Characteristic of Venous Thromboembolism in Gynecologic Oncology Patients attending King Chulalongkorn Memorial Hospital over a 10 Year Period.
Oranratanaphan S; Termrungruanglert W; Khemapech N
Asian Pac J Cancer Prev; 2015; 16(15):6705-9. PubMed ID: 26434898
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis.
Di Nisio M; Candeloro M; Rutjes AWS; Porreca E
J Thromb Haemost; 2018 Jul; 16(7):1336-1346. PubMed ID: 29754426
[TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factors of preoperative venous thromboembolism and pulmonary embolism in patients with ovarian cancer.
Liang S; Tang W; Ye S; Xiang L; Wu X; Yang H
Thromb Res; 2020 Jun; 190():129-134. PubMed ID: 32361343
[TBL] [Abstract][Full Text] [Related]
15. Risk of venous thromboembolism for ovarian cancer patients during first-line therapy after implementation of an Enhanced Recovery After Surgery (ERAS) protocol.
Li S; Bercow AS; Falzone M; Kalyanaraman R; Worley MJ; Feltmate CM; Pelletier A; Elias KM
Gynecol Oncol; 2021 Aug; 162(2):353-359. PubMed ID: 34092412
[TBL] [Abstract][Full Text] [Related]
16. Incidence of venous thromboembolism in patients with sickle cell disease undergoing noncardiovascular surgery.
Osei SK; Long GW; Sharrak A; Derias N; Goodson R; Callahan RE; Studzinski DM; Brown OW
J Vasc Surg Venous Lymphat Disord; 2023 May; 11(3):543-552. PubMed ID: 36574902
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism risk in patients receiving neoadjuvant chemotherapy for bladder cancer.
Garas SN; McAlpine K; Ross J; Carrier M; Bossé D; Yachnin D; Mallick R; Cagiannos I; Morash C; Breau RH; Lavallée LT
Urol Oncol; 2022 Aug; 40(8):381.e1-381.e7. PubMed ID: 35581123
[TBL] [Abstract][Full Text] [Related]
18. Implementation of routine venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer.
McLaughlin HD; Greco P; Straubhar AM; Rolston A; McCool K; Brackmann M; Siedel JH; McLean K; Reynolds RK; Uppal S
Gynecol Oncol; 2023 Nov; 178():89-95. PubMed ID: 37832182
[TBL] [Abstract][Full Text] [Related]
19. High incidence of silent venous thromboembolism before treatment in ovarian cancer.
Satoh T; Oki A; Uno K; Sakurai M; Ochi H; Okada S; Minami R; Matsumoto K; Tanaka YO; Tsunoda H; Homma S; Yoshikawa H
Br J Cancer; 2007 Oct; 97(8):1053-7. PubMed ID: 17895896
[TBL] [Abstract][Full Text] [Related]
20. Incidence and risk factors for postoperative venous thromboembolism in patients with ovarian cancer: Systematic review and meta-analysis.
Xu Y; Jia Y; Zhang Q; Du Y; He Y; Zheng A
Gynecol Oncol; 2021 Feb; 160(2):610-618. PubMed ID: 33221022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
